Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.28 M
Marketcap
5,54ย โ‚ฌ
Share price
2.54%
Change (1 day)
-65.09%
Change (1 year)

Revenue for Cel-Sci (CVM)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cel-Sci from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A-100%
2012 โ‚ฌ0.08 M-63.84%
2011 โ‚ฌ0.22 M-56.69%
2010 โ‚ฌ0.52 M1145.37%
2009 โ‚ฌ0.04 M
2007 โ‚ฌ0.02 M-68.81%
2006 โ‚ฌ0.08 M-54.95%
2005 โ‚ฌ0.18 M-23.77%
2004 โ‚ฌ0.24 M-10.16%
2003 โ‚ฌ0.26 M28.86%
2002 โ‚ฌ0.2 M-33.54%
2001 โ‚ฌ0.31 M-59.52%
2000 โ‚ฌ0.77 M56.1%
1999 โ‚ฌ0.49 M47.41%
1998 โ‚ฌ0.33 M-33.33%
1997 โ‚ฌ0.5 M50%
1996 โ‚ฌ0.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Curis
CRIS
โ‚ฌ10 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.51 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.89 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ79.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.64 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ0 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA